Osteogenic Differentiation of Human Amniotic Fluid Mesenchymal Stem Cells Is Determined by Epigenetic Changes
Monika Glemžaitė(Vilnius University), Rūta Navakauskienė(Vilnius University)
Cited by 26
Related Papers
Pharmaceutical Drug Metformin and MCL1 Inhibitor S63845 Exhibit Anticancer Activity in Myeloid Leukemia Cells via Redox Remodeling
|Molecules|2021|15
Effects of human placenta cryopreservation on molecular characteristics of placental mesenchymal stromal cells
|Frontiers in Bioengineering and Biotechnology|2023|11
The Effect of Angiotensin II, Retinoic Acid, EGCG, and Vitamin C on the Cardiomyogenic Differentiation Induction of Human Amniotic Fluid-Derived Mesenchymal Stem Cells
|International Journal of Molecular Sciences|2020|10
Effect of 3D Spheroid Culturing on NF-κB Signaling Pathway and Neurogenic Potential in Human Amniotic Fluid Stem Cells
|International Journal of Molecular Sciences|2023|3